Then there were also the comments from the August 2015 interview of Skippen in The Director where the acquisition was extensively referenced including as an opportunity to gain critical mass in just one (rather than a number of) transaction(s).
The summary touch of - caveat emptor - is fascinating. More like that plus caution being thrown to the wind.
The reference to the external fees if $51.6m is equally fascinating as, if so, then this would not have included their own internal working costs. Put these all together and you get to an acquisition DD cost of upwards of 5-7% of acquisition value depending on which metric you use. Now, all things being equal, that's some serious firepower - or meant to be.
Clearly, this will be a serious, extended and exhausting fight for those concerned.
- Forums
- ASX - By Stock
- WTG Defence
SGH
sgh limited
Add to My Watchlist
1.10%
!
$51.40

Then there were also the comments from the August 2015 interview...
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$51.40 |
Change
-0.570(1.10%) |
Mkt cap ! $20.91B |
Open | High | Low | Value | Volume |
$52.74 | $52.74 | $51.24 | $18.10M | 351.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 245 | $51.20 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$51.46 | 1043 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 245 | 51.200 |
1 | 115 | 51.100 |
1 | 55 | 51.010 |
1 | 98 | 50.850 |
1 | 105 | 50.800 |
Price($) | Vol. | No. |
---|---|---|
51.460 | 600 | 1 |
51.590 | 445 | 1 |
52.050 | 500 | 1 |
52.470 | 258 | 1 |
52.700 | 95 | 1 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
SGH (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online